Effects of citalopram on blood pressure

Effects of citalopram on blood pressure control in patients with hypertension: randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111206008307N32

Enrollment

Registered

2019-10-22

Start date

2018-09-22

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hypertension. Condition 2: Depression. Essential (primary) hypertension Major depressive disorder, single episode

Interventions

Intervention 1: Intervention group: Patients in this group received citaloprm 20 mg, once per day orally plus anti hypertensive standard treatment for 2 months.All of the drugs used in this study are

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hypertensive patients with diagnosis of depresion based on HAM-D scale Informed consent of patien

Exclusion criteria

Exclusion criteria: Secondary hypertension Pregnancy and lactation Contraindications of citalopram Mild or moderate depression based on HAM-D scale Contraindications of anti-hypertensive drugs

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: Measurement of blood pressure before intervention and two months after intervention. Method of measurement: Mercury manometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTaher Entezari Maleki

Tabriz University of Medical Sciences

tentezari@gmail.com+98 41 3337 2250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026